NRG NCORP Research Base Clinical Trials
Links to recently activated NRG NCORP-supported clinical trials are listed below. In addition, the program supports trials formerly conducted by the legacy groups’ Community Clinical Oncology Program (CCOP) Research Base programs that are now part of the NRG Oncology. Information about these trials can be found on the groups' legacy websites.
NRG-CC005 (FORTE): Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NRG-CC007CD: Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
NRG-CC008: A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
NRG-CC009: Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or Fewer Brain Metastases from Small Cell Lung Cancer
NRG-CC010: A Phase III Trial of the Impact of Sentinel Lymph Node Mapping On Patient Reported Lower Extremity Limb Dysfunction in Endometrial Cancer
NRG-CC011: Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial
NRG-CC012CD: Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
NRG-CC013: A Randomized, Masked, Placebo Controlled, Phase II Trial of Concurrent Chemoradiation with BMX-001 in Patients with Head and Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
